The World Largest manufacturer Factory Sales Highest Quality Iron Dextran CAS 9004-66-4

                                            Inquiry email: info@leader-biogroup.com

 Hot Line +86-029-68895030

                +86-029-68569961

                 +86-029-68569962

         Fax +86-029-68895030

Iron-dextran Basic information Product Name: Iron-dextran Synonyms: fe-dextran;fenate;ferdex100;ferricdextran;ferridextran;ferrodextran;ferroglucin;ferroglukin75 CAS: 9004-66-4 MF: FeH2O4S MW: 153.92348 EINECS: 202-785-7 Product Categories: API;API's Mol File: 9004-66-4.mol   Iron-dextran Chemical Properties form solution IARC 2B (Vol. 2, Sup 7) 1987 EPA Substance Registry System Iron dextran (9004-66-4)   Safety Information Hazard Codes Xn,T Risk Statements 40-42/43-43-45 Safety Statements 23-26-36/37/39-45-36-36/37-53 WGK Germany - RTECS NI2200000 Hazardous Substances Data 9004-66-4(Hazardous Substances Data) Toxicity LD50 i.v. in mice: 2240 mg Fe/kg (Beliles) MSDS Information Provider Language Ferric hydroxide dextran complex English SigmaAldrich English   Iron-dextran Usage And Synthesis Description Iron dextran is a dark brown, slightly viscous liquid complex of ferric hydroxide and dextran for intravenous or intramuscular use. Iron Dextran is used for the treatment of patients with documented iron deficiency in which oral administration is unsatisfactory or impossible. It is supplied as a parenteral preparation and is used as a hematinic. (Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed, p1292) Iron-Dextran is for the parenteral treatment of iron-deficiency anemia in humans and baby pigs. Can be used as a reagent. Chemical Properties Light to dark brown powder. Colloidal suspension of an iron-dextran complex in water. pH 5.2-6.5. History The therapeutic value of colloidal iron preparations was first reported in the 1950's by London and Twigg. Numerous attempts have been made to improve these iron preparations Thus dextran ([h] 0.05) is first heated with alkali, and is then neutralized in the presence of ferric chloride solution. Studies on this product have revealed that each particle consists of a central iron core, approximately 3nm diameter, surrounded by a dextran sheath of approximately 13nm diameter. The complex is visualized as a particle formed by a protective sheath of dextran attached by terminal metasaccharinic acid units to a b-FeOOH core. A solution of this complex containing 5% iron and 20% dextran (Imferon ™ ) is suitable for intramuscular and intravenous injection for treating iron deficiency anemia. The product is currently used widely for treating anemia in new-born piglets. The use of these preparations has been re-examined in humans and a dramatic rise in hemoglobin was reported following intravenous infusion. The solution is best administered togr with glucose solutions. Uses Hematinic. Brand name Dexferrum (Luitpold); Infed (Wat son); Proferdex (New River). Reactivity Profile Iron-dextran is unstable at a pH of 5 and decomposes at 149-158° F. Iron-dextran may be sensitive to prolonged exposure to air. Health Hazard SYMPTOMS: The symptoms associated with exposure to Iron-dextran are headaches, vomiting, and dizziness. Fire Hazard Iron-dextran is combustible. Carcinogenicity Iron dextran complex is reasonably anticipated to be a human carcinogen based on sufficient evidence of carcinogenicity from studies in experimental animals.   Iron-dextran Preparation Products And Raw materials Preparation Products Dextran